Smart micelleplexes as a new therapeutic approach for RNA delivery

References

• Guerrier-Takada C, Gardiner K, Marsh T, et al. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell. 1983;35:849–857.
   PubMed Web of Science ®Google Scholar
• Kruger K, Grabowski PJ, Zaug AJ, et al. Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena. Cell. 1982;31:147–157.
   PubMed Web of Science ®Google Scholar
• Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806–811.
   PubMed Web of Science ®Google Scholar
• Burnett JC, Rossi JJ. RNA-based therapeutics: current progress and future prospects. Chem Biol. 2012;19:60–71.
   PubMed Web of Science ®Google Scholar
• Bumcrot D, Manoharan M, Koteliansky V, et al. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol. 2006;2:711–719.
   PubMed Web of Science ®Google Scholar
• Deng Y, Wang CC, Choy KW, et al. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies. Gene. 2014;538:217–227.
   PubMed Web of Science ®Google Scholar
• Pascolo S. Vaccination with messenger RNA. Methods Mol Med. 2006;127:23–40.
   PubMedGoogle Scholar
• Murray RK, Granner DK, Mayes PA, et al. Harper´s biochemistry. 25th ed. New York: McGraw-Hill; 2000.
   Google Scholar
• Bernat V, Disney MD. RNA structures as mediators of neurological diseases and as drug targets. Neuron. 2015;87:28–46.
   PubMed Web of Science ®Google Scholar
• Soll D, Nishimura S, Moore P. RNA. 1st ed. Oxford: Pergamon; 2001.
   Google Scholar
• Kreiter S, Diken M, Selmi A, et al. Tumor vaccination using messenger RNA: prospects of a future therapy. Curr Opin Immunol. 2011;23:399–406.
   PubMed Web of Science ®Google Scholar
• Matera AG, Terns RM, Terns MP. Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs. Nat Rev Mol Cell Biol. 2007;8:209–220.
   PubMed Web of Science ®Google Scholar
• Raam BJ, Salvesen GS. Transferring death: a role for tRNA in apoptosis regulation. Mol Cell. 2010;37:591–592.
   PubMed Web of Science ®Google Scholar
• Dogini DB, Pascoal VD, Avansini SH, et al. The new world of RNAs. Genet Mol Biol. 2014;37:285–293.
   PubMed Web of Science ®Google Scholar
• Nie L, Wu HJ, Hsu JM, et al. Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer. Am J Transl Res. 2012;4(2):127–150.
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhang JL, Yu XL, et al. Molecular functions of small regulatory noncoding RNA. Biochemistry (Mosc). 2013;78(3):221–230.
   PubMed Web of Science ®Google Scholar
• Gomes AQ, Nolasco S, Soares H. Non-coding RNAs: multi-tasking molecules in the cell. Int J Mol Sci. 2013;14:16010–16039.
   PubMed Web of Science ®Google Scholar
• Chu CY, Rana TM. Small RNAs: regulators and guardians of the genome. J Cell Physiol. 2007;213:412–419.
   PubMed Web of Science ®Google Scholar
• Kim VN. Small RNAs: classification, biogenesis, and function. Mol Cells. 2005;19:1–15.
   PubMed Web of Science ®Google Scholar
• Brantl S. Antisense-RNA regulation and RNA interference. Biochim Biophys Acta. 2002;1575:15–25.
   PubMed Web of Science ®Google Scholar
• Phylactou LA, Kilpatrick MW, Wood MJ. Ribozymes as therapeutic tools for genetic disease. Hum Mol Genet. 1998;7:1649–1653.
   PubMed Web of Science ®Google Scholar
• Mayer G. The chemical biology of aptamers. Angew Chem Int Ed Engl. 2009;48:2672–2689.
   PubMed Web of Science ®Google Scholar
• Wittmann A, Suess B. Engineered riboswitches: expanding researchers’ toolbox with synthetic RNA regulators. FEBS Lett. 2012;586:2076–2083.
   PubMed Web of Science ®Google Scholar
• Blount KF, Breaker RR. Riboswitches as antibacterial drug targets. Nat Biotechnol. 2006;24:1558–1564.
   PubMed Web of Science ®Google Scholar
• Milhavet O, Gary DS, Mattson MP. RNA interference in biology and medicine. Pharmacol Rev. 2003;55:629–648.
   PubMed Web of Science ®Google Scholar
• Sullenger BA, Gilboa E. Emerging clinical applications of RNA. Nature. 2002;418:252–258.
   PubMed Web of Science ®Google Scholar
• Ponsaerts P, Van Tendeloo VF, Berneman ZN. Cancer immunotherapy using RNA-loaded dendritic cells. Clin Exp Immunol. 2003;134:378–384.
   PubMed Web of Science ®Google Scholar
• Van Lint S, Heirman C, Thielemans K, et al. mRNA: from a chemical blueprint for protein production to an off-the-shelf therapeutic. Hum Vaccin Immunother. 2013;9:265–274.
   PubMed Web of Science ®Google Scholar
• Gavrilov K, Saltzman WM. Therapeutic siRNA: principles, challenges, and strategies. Yale J Biol Med. 2012;85:187–200.
   PubMedGoogle Scholar
• Pathak A, Patnaik S, Gupta KC. Recent trends in non-viral vector-mediated gene delivery. Biotechnol J. 2009;4:1559–1572.
   PubMedGoogle Scholar
• Wittrup A, Lieberman J. Knocking down disease: a progress report on siRNA therapeutic. Nat Rev Genet. 2015;16(9):543–552.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang C, Liang W. Development of RNAi technology for targeted therapy - A track of siRNA based agents to RNAi therapeutics. J Control Release. 2014;193:270–281.
   PubMed Web of Science ®Google Scholar
• Ozcan G, Ozpolat B, Coleman RL, et al. Preclinical and clinical development of siRNA-based therapeutics. Adv Drug Deliv Rev. 2015;87:108–119.
   PubMed Web of Science ®Google Scholar
• Gallas A, Alexander C, Davies MC, et al. Chemistry and formulations for siRNA therapeutics. Chem Soc Rev. 2013;42:7983.
   PubMed Web of Science ®Google Scholar
• El-Sagheer AH, Brown T. New strategy for the synthesis of chemically modified RNA constructs exemplified by hairpin and hammerhead ribozymes. Proc Natl Acad Sci U S A. 2010;107:15329–15334.
   PubMed Web of Science ®Google Scholar
• Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov. 2014;13:622–638.
   PubMed Web of Science ®Google Scholar
• Singh S, Narang AS, Mahato RI. Subcellular fate and off-target effects of siRNA, shRNA, and miRNA. Pharm Res. 2011;28:2996–3015.
   PubMed Web of Science ®Google Scholar
• Wang Z, Rao DD, Senzer N, et al. RNA interference and cancer therapy. Pharm Res. 2011;28:2983–2995.
   PubMed Web of Science ®Google Scholar
• Ballarin-Gonzalez B, Howard KA. Polycation-based nanoparticle delivery of RNAi therapeutics: adverse effects and solutions. Adv Drug Deliv Revi. 2012;64:1717–1729.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang Z, Gemeinhart RA. Progress in microRNA delivery. J Control Release. 2013;172:962–974.
   PubMed Web of Science ®Google Scholar
• Mintzer MA, Simanek EE. Non-viral vectors for gene delivery. Chem Rev. 2009;109:259–302.
   PubMed Web of Science ®Google Scholar
• Robbins PD, Tahara H, Ghivizzani SC. Viral vectors for gene therapy. Trends Biotechnol. 1998;16:35–40.
   PubMed Web of Science ®Google Scholar
• Walther W, Stein U. Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs. 2000;60:249–271.
   PubMed Web of Science ®Google Scholar
• Gao K, Huang L. Nonviral methods for siRNA delivery. Mol Pharm. 2009;6:651–658.
   PubMed Web of Science ®Google Scholar
• De Smedt SC, Demeester J, Hennink WE. Cationic polymer based gene delivery systems. Pharm Res. 2000;17:113–126.
   PubMed Web of Science ®Google Scholar
• Park TG, Jeong JH, Kim SW. Current status of polymeric gene delivery systems. Adv Drug Deliv Rev. 2006;58:467–486.
   PubMed Web of Science ®Google Scholar
• Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release. 2002;82:189–212.
   PubMed Web of Science ®Google Scholar
• Yin H, Kanasty RL, Eltoukhy AA, et al. Non-viral vectors for gene-based therapy. Nat Rev Genet. 2014;15:541–555.
   PubMed Web of Science ®Google Scholar
• Kore G, Kolate A, Nej A, et al. Polymeric micelle as multifunctional pharmaceutical carriers. J Nanosci Nanotechnol. 2014;14(1):288–307.
   PubMed Web of Science ®Google Scholar
• Jhaveri AM, Torchilin VP. Multifunctional polymeric micelles for delivery of drugs and siRNA. Front Pharmacol. 2014;5:77.
   PubMed Web of Science ®Google Scholar
• Navarro G, Pan J, Torchilin VP. Micelle-like nanoparticles as carriers for DNA and siRNA. Mol Pharmaceutics. 2015;12(2):301–313.
   PubMed Web of Science ®Google Scholar
• Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev. 2001;47(1):113–131.
   PubMed Web of Science ®Google Scholar
• Kakizawa Y, Kataoka K. Block copolymer micelles for delivery of gene and related compounds. Adv Drug Deliv Rev. 2002;54(2):203–222.
   PubMed Web of Science ®Google Scholar
• Miyata K, Christie RJ, Kataoka K. Polymeric micelles for nano-scale drug delivery. React Funct Polym. 2011;71(3):227–234.
   Web of Science ®Google Scholar
• Cabral H, Nishiyama N, Kataoka K. Supramolecular nanodevices: from design validation to theranostic nanomedicine. Acc Chem Res. 2011; 44(10):999–1008.
   PubMed Web of Science ®Google Scholar
• Cabral H, Kataoka K. Progress of drug-loaded polymeric micelles into clinical studies. J Control Release. 2014;190:465–476.
   PubMed Web of Science ®Google Scholar
• Kataoka K, Togawa H, Harada A, et al. Spontaneous formation of polyion complex micelles with narrow distribution form antisense oligonucleotide and cationic block copolymer in physiological saline. Macromolecules. 1996;29:8556–8557.
   Web of Science ®Google Scholar
• Laus M, Sparnacci K, Ensoli B, et al. Complex associates of plasmid DNA and a novel class of block copolymers with PEG and cationic segments as new vectors for gene delivery. J Biomater Sci Polymer Ed. 2001;12:209–228.
   PubMed Web of Science ®Google Scholar
• Christie RJ, Miyata K, Matsumoto Y, et al. Effect of polymer structure on micelles formed between siRNA and cationic block copolymer comprising thiols and amidines. Biomacromolecules. 2011;12:3174–3185.
   PubMed Web of Science ®Google Scholar
• Simões SMN, Figueiras A, Veiga F, et al. Polymeric micelles for oral drug administration enabling loco-regional and systemic treatment. Expert Opin Drug Deliv. 2014;17:1–22.
   Google Scholar
• Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46(12 Pt 1):6387–6392.
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63(3):136–151.
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65(1–2):271–284.
   PubMed Web of Science ®Google Scholar
• Gaucher G, Dufresne MH, Sant VP, et al. Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release. 2005;109:169–188.
   PubMed Web of Science ®Google Scholar
• Kedar U, Phutane P, Shidhaye S, et al. Advances in polymeric micelles for drug delivery and tumor targeting. Nanomed Nanotech Biol Med. 2010;6(6):714–729.
   PubMed Web of Science ®Google Scholar
• Savić R, Eisenberg A, Maysinger D. Block copolymer micelles as delivery vehicles of hydrophobic drugs: micelle-cell interactions. J Drug Target. 2006;14(6):343–355.
   PubMed Web of Science ®Google Scholar
• Allen C, Maysinger D, Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloid Surf B Biointerfaces. 1999;16:3–27.
   Web of Science ®Google Scholar
• Manaspon C, Viravaidya-Pasuwat K, Pimpha N. Preparation of folate conjugated pluronic F127/chitosan core-shell nanoparticles encapsulating doxorubicin for breast cancer treatment. J Nanomater. 2012;2012:1–11.
   Web of Science ®Google Scholar
• Chiappetta DA, Sosnik A. Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs. Eur J Pharm Biopharm. 2007;66:303–317.
   PubMed Web of Science ®Google Scholar
• Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev. 2002;54(5):759–779.
   PubMed Web of Science ®Google Scholar
• Li N, Yang X, Zhai G, et al. Multifunctional pluronic/poly(ethylenimine) nanoparticles for anticancer drug. J Colloid Interface Sci. 2010;350:117–125.
   PubMed Web of Science ®Google Scholar
• Pereira P, Jorge AF, Martins R, et al. Characterization of polyplexes involving small RNA. J Colloid Interface Sci. 2012;387:84–94.
   PubMed Web of Science ®Google Scholar
• De Smedt SC, Demeester J, Hennink WE. Cationic polymer based gene delivery systems. Pharm Res. 2000;17(2):113–126.
   PubMed Web of Science ®Google Scholar
• Tros De Ilarduya C, Sun Y, Düzgüneş N. Gene delivery by lipoplexes and polyplexes. Eur J Pharm Sci. 2010;40(3):159–170.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev. 2012;64:302–315.
   Web of Science ®Google Scholar
• Lai TC, Kataoka K, Kwon GS. Pluronic-based cationic block copolymer for forming pDNA polyplexes with enhanced cellular uptake and improved transfection efficiency. Biomaterials. 2011;32:4594–4603.
   PubMed Web of Science ®Google Scholar
• Lai TC, Kataoka K, Kwon GS. Bioreducible polyether-based pDNA ternary polyplexes: balancing particle stability and transfection efficiency. Colloids Surf B Biointerfaces. 2012;99:27–37.
   PubMed Web of Science ®Google Scholar
• Chèvre R, Le Bihan O, Beilvert F, et al. Amphiphilic block copolymers enhance the cellular uptake of DNA molecules through a facilitated plasma membrane transport. Nucleic Acids Res. 2011;39:1610–1622.
   PubMed Web of Science ®Google Scholar
• Borchard G. Chitosans for gene delivery. Adv Drug Deliv Rev. 2001;52(2):145–150.
   PubMed Web of Science ®Google Scholar
• Bromberg L, Raduyk S, Hatton TA, et al. Guanidinylated polyethyleneimine-polyoxypropylene-polyoxyethylene conjugates as gene transfection agents. Bioconjug Chem. 2009;20(5):1044–1053.
   PubMed Web of Science ®Google Scholar
• Kuo JH. Effect of Pluronic-block copolymers on the reduction of serum-mediated inhibition of gene transfer of polyethyleneimine-DNA complexes. Biotechnol Appl Biochem. 2003;37:267–271.
   PubMed Web of Science ®Google Scholar
• Ogris M, Steinlein P, Carotta S, et al. DNA/polyethylenimine transfection particles : influence of ligands, polymer size, and PEGylation on internalization and gene expression. AAPS PharmSci. 2001;3(3):43–53.
   Google Scholar
• Boussif O, Lezoualc’h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A. 1995;92(16):7297–7301.
   PubMed Web of Science ®Google Scholar
• Katas H, Cevher E, Alpar HO. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery. Int J Pharm. 2009;369(1–2):144–154.
   PubMed Web of Science ®Google Scholar
• Sutton D, Nasongkla N, Blanco E, et al. Functionalized micellar systems for cancer targeted drug delivery. Pharm Res. 2007;24:1029–1046.
   PubMed Web of Science ®Google Scholar
• Gary DJ, Lee H, Sharma R, et al. Influence of nano-carrier architecture on in vitro siRNA delivery performance and in vivo biodistribution: polyplexes vs micelleplexes. ACS Nano. 2011;5(5):3493–3505.
   PubMed Web of Science ®Google Scholar
• Lee SY, Yang CY, Peng CL, et al. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy. Biomaterials. 2016;86:92–105.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Y, Sen S, et al. Charged group surface accessibility determines micelleplexes formation and cellular interaction. Nanoscale. 2015;7(17):7559–7564.
   PubMed Web of Science ®Google Scholar
• Jones SK, Lizzio V, Merkel O. Folate receptor targeted delivery of siRNA and paclitaxel to ovarian cancer cells via folate conjugated triblock copolymer to overcome TLR4 driven chemotherapy resistance. Biomacromolecules. 2016;17(1):76–87.
   PubMed Web of Science ®Google Scholar
• Lin D, Jiang Q, Cheng Q, et al. Polycation-detachable nanoparticles self-assembled from mPEG-PCL-g-SS-PDMAEMA for in vitro and in vivo siRNA delivery. Acta Biomater. 2013;9(8):7746–7757.
   PubMed Web of Science ®Google Scholar
• Yu H, Guo C, Feng B, et al. Triple-layered pH-responsive micelleplexes loaded with siRNA and cisplatin prodrug for NF-kappa B targeted treatment of metastatic breast cancer. Theranostics. 2016;6(1):14–27.
   PubMed Web of Science ®Google Scholar
• Kim Y-M, Song S-C. Targetable micelleplex hydrogel for long-term, effective, and systemic siRNA delivery. Biomaterials. 2014;35(27):7970–7977.
   PubMed Web of Science ®Google Scholar
• Yu H, Xu Z, Chen X, et al. Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel. Macromol Biosci. 2014;14(1):100–109.
   PubMed Web of Science ®Google Scholar
• Zhao ZX, Gao SY, Wang JC, et al. Self-assembly nanomicelles based on cationic mPEG-PLA-b-Polyarginine(R15) triblock copolymer for siRNA delivery. Biomaterials. 2012;33(28):6793–6807.
   PubMed Web of Science ®Google Scholar
• Yu H, Zou Y, Wang Y, et al. Overcoming endosomal barrier by amphotericin B-loaded dual pH-responsive PDMA-b-PDPA micelleplexes for siRNA delivery. ACS Nano. 2011;5(11):9246–9255.
   PubMed Web of Science ®Google Scholar
• Liu L, Zheng M, Librizzi D, et al. Efficient and tumor targeted siRNA delivery mediated by polyethylenimine-graft-polycaprolactone-block-poly (ethylene glycol)-folate (PEI- PCL-PEG-Fol). Mol Pharmaceutics. 2016;13(1):134–143.
   PubMed Web of Science ®Google Scholar
• Cheng C, Convertine AJ, Stayton PS, et al. Multifunctional triblock copolymers for intracellular messenger RNA delivery. Biomaterials. 2012;33(28):6868–6876.
   PubMed Web of Science ®Google Scholar
• Huo H, Gao Y, Wang Y, et al. Polyion complex micelles composed of pegylated polyasparthydrazide derivatives for siRNA delivery to the brain. J Colloid Interface Sci. 2015;447:8–15.
   PubMed Web of Science ®Google Scholar
• Kumar V, Mondal G, Slavik P, et al. Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer. Mol Pharm. 2015;12(4):1289–1298.
   PubMed Web of Science ®Google Scholar
• Salzano G, Navarro G, Trivedi MS, et al. Multifunctional polymeric micelles co-loaded with anti-survivin siRNA and paclitaxel overcome drug resistance in an animal model of ovarian cancer. Mol Cancer Ther. 2015;14(4):1075–1084.
   PubMed Web of Science ®Google Scholar
• Qian J, Xu M, Suo A, et al. Folate-decorated hydrophilic three-arm star-block terpolymer as a novel nanovehicle for targeted co-delivery of doxorubicin and Bcl-2 siRNA in breast cancer therapy. Acta Biomater. 2015;15:102–116.
   PubMed Web of Science ®Google Scholar
• Li X, Yu Y, Ji Q, et al. Targeted delivery of anticancer drugs by aptamer AS1411 mediated Pluronic F127/cyclodextrin-linked polymer composite micelles. Nanomedicine. 2015;11(1):175–184.
   PubMed Web of Science ®Google Scholar
• Oe Y, Christie RJ, Naito M, et al. Actively-targeted polyion complex micelles stabilized by cholesterol and disulfide cross-linking for systemic delivery of siRNA to solid tumors. Biomaterials. 2014;35(27):7887–7895.
   PubMed Web of Science ®Google Scholar
• Mittal A, Chitkara D, Behrman SW, et al. Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer. Biomaterials. 2014;35(25):7077–7087.
   PubMed Web of Science ®Google Scholar
• Qian X, Long L, Shi Z, et al. Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma. Biomaterials. 2014;35(7):2322–2335.
   PubMed Web of Science ®Google Scholar
• Kanazawa T, Akiyama F, Kakizaki S, et al. Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles. Biomaterials. 2013;34(36):9220–9226.
   PubMed Web of Science ®Google Scholar
• Chan DP, Deleavey GF, Owen SC, et al. Click conjugated polymeric immuno-nanoparticles for targeted siRNA and antisense oligonucleotides delivery. Biomaterials. 2013;34(33):8408–8415.
   PubMed Web of Science ®Google Scholar
• Zheng C, Zheng M, Gong P, et al. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy. Biomaterials. 2013;34(13):3431–3438.
   PubMed Web of Science ®Google Scholar
• Wang HX, Xiong MH, Wang YC, et al. N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver. J Control Release. 2013;166(2):106–114.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhu W, Liu Y, et al. Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy. Sci Rep. 2016;6:23859.
   PubMed Web of Science ®Google Scholar
• Cho K, Wang X, Nie S, et al. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res. 2008;14:1310–1316.
   PubMed Web of Science ®Google Scholar
• Medina-Kauwe LK, Xie J, Hamm-Alvarez S. Intracellular trafficking of nonviral vectors. Gene Ther. 2005;12:1734–1751.
   PubMed Web of Science ®Google Scholar
• Gupta B, Levchenko TS, Torchilin VP. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv Drug Deliv Rev. 2005;57:637–651.
   PubMed Web of Science ®Google Scholar
• Caracciolo G, Caminiti R, Digman MA, et al. Efficient escape from endosomes determines the superior efficiency of multicomponent lipoplexes. J Phys Chem B. 2009;113:4995–4997.
   PubMed Web of Science ®Google Scholar
• Dominska M, Dykxhoorn DM. Breaking down the barriers: siRNA delivery and endosome escape. J Cell Sci. 2010;123:1183–1189.
   PubMed Web of Science ®Google Scholar
• Varkouhi AK, Scholte M, Storm G, et al. Endosomal escape pathways for delivery of biological. J Control Release. 2011;151:220–228.
   PubMed Web of Science ®Google Scholar
• Nguyen DN, Green JJ, Chan JM, et al. Polymeric materials for gene delivery and DNA vaccination. Adv Mater. 2009;21:847–867.
   PubMed Web of Science ®Google Scholar
• Wang AZ, Gu F, Zhang L, et al. Biofunctionalized targeted nanoparticles for therapeutic applications. Expert Opin Biol Ther. 2008;8:1063–1070.
   PubMed Web of Science ®Google Scholar
• Xu W, Cui Y, Ling P, et al. Preparation and evaluation of folate-modified cationic pluronic micelles for poorly soluble anticancer drug. Drug Delivery. 2012;19(4):208–219.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhou Y, De B, et al. Folate-modified pluronic-polyethylenimine and cholic acid polyion complex micelles as targeted drug delivery system for paclitaxel. J Microencapsul. 2014;31(8):805–814.
   Google Scholar